Arete Wealth Advisors’s Halozyme HALO Stock Holding History

Arete Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150,220	Closed	-$3.88M	–	421
2020 Q3	$3.88M	Hold	150,220	–	–	0.58%	37
2020 Q2	$4.03M	Hold	150,220	–	–	0.7%	30
2020 Q1	$2.7M	Buy	150,220 +220	+0.1%	+$4.18K	0.53%	39
2019 Q4	$2.66M	Sell	150,000 -86,540	-37%	-$1.5M	0.46%	57
2019 Q3	$3.67M	Hold	236,540	–	–	0.7%	27
2019 Q2	$4.06M	Hold	236,540	–	–	0.79%	22
2019 Q1	$3.81M	Hold	236,540	–	–	0.79%	22
2018 Q4	$3.46M	Buy	+236,540	New	+$3.77M	0.84%	20

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arete Wealth Advisors's HALO Position: Q4 2020 in Review

Arete Wealth Advisors sold out of Halozyme (HALO) in Q4 2020, closing a stake of 150,220 shares — an estimated $3.88M sold.

Arete Wealth Advisors first reported a position in HALO in Q4 2018 and held it in 8 quarters. The position peaked at $4.06M in Q2 2019. 342 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

Arete Wealth Advisors reported no remaining Halozyme position as of Q4 2020 after selling out during the quarter.
Arete Wealth Advisors sold 150,220 Halozyme shares in Q4 2020, an estimated $3.88M.
Arete Wealth Advisors first reported a position in Halozyme in Q4 2018 and held it in 8 quarters.
Arete Wealth Advisors's Halozyme position peaked at $4.06M in Q2 2019.
342 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Arete Wealth Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.